Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Hawaii J Med Public Health ; 72(12): 428-32, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24377077

ABSTRACT

This study aims to demonstrate the feasibility of implementing single-incision laparoscopic cholecystectomy in a community hospital setting. Minimally invasive surgical approaches for cholecystectomy achieve equivalent outcomes to the open surgical approach with less post-operative pain, improved cosmesis, shorter hospital stays, and decreased complications. Surgeons are attempting to reduce incisional trauma further by decreasing the number of incisions. A retrospective chart review was conducted for demographics, operating time, blood loss, conversion rate, length of stay, and presence of operative complications on patients undergoing single-incision laparoscopic cholecystectomy at two community hospitals between 2008 and 2011. One hundred and three patients (79 females and 24 males) underwent single-incision laparoscopic cholecystectomy. The mean age was 49.8 years (range 18-88). Ninety-six patients (93.2%) underwent elective procedures while 7 patients (6.8%) underwent urgent procedures. The mean operating time was 89.7 (± 28.3) minutes and the average blood loss was 33.7 (± 27.4) milliliters. Ninety-five (92.2%) of the procedures were successfully completed with a single-incision approach and 8 (7.8%) were converted to a multi-incisional approach, while none were converted to an open approach. The median length of stay was 4.75 hours. The post-operative complication rate was 7.4% (7/95) and included four superficial wound infections, one bile leak, one acute renal failure, and one urinary tract infection. These outcomes for single-incision laparoscopic cholecystectomy are comparable to other case series reported in the literature, and this retrospective review illustrates that single-incision laparoscopic cholecystectomy is feasible in a community setting.


Subject(s)
Cholecystectomy, Laparoscopic/methods , Adolescent , Adult , Aged , Aged, 80 and over , Feasibility Studies , Female , Hawaii , Hospitals, Community , Humans , Male , Middle Aged , Retrospective Studies
2.
Cancer J ; 12(4): 318-26, 2006.
Article in English | MEDLINE | ID: mdl-16925977

ABSTRACT

PURPOSE: Long-term follow-up data of radiofrequency ablation (RFA) for patients with unresectable metastatic liver tumors from colorectal cancer have rarely been reported. This study was undertaken to evaluate long-term outcome of RFA in relation to its timing opposite chemotherapy, and to identify prognostic factors associated with survival. PATIENTS AND METHODS: Patients undergoing RFA from 1997 to 2003 were monitored. Data were prospectively collected and retrospectively reviewed. RESULTS: RFA was performed for 100 patients in 146 procedures to ablate 507 colorectal metastatic tumors. All patients were followed up for at least 18 months or until death, up to 84 months: the median follow-up was 24.5 months. The overall median survival was 28 months, and 1-, 3-, and 5-year survival was 90.0%, 42.0%, and 30.5%, respectively. The recurrence-free median survival was 13 months. Median survival was 48 months among 55 patients (55%) who received RFA (first-line) before initiation of chemotherapy, versus 22 months among 45 patients (45%) who received RFA (second-line) for residual or progressive metastatic disease after chemotherapy. Significant factors affecting overall survival were carcinoembryonic antigen level (200 ng/mL), total tumor size (sum diameter of tumors, 100 mm), RFA approach, previous therapeutic chemotherapy by a univariate analysis, age (70 years) by a multivariate analysis, and extrahepatic metastasis by both analyses. DISCUSSION: RFA can contribute to encouraging long-term survival. Prognostic factors have been identified. Compared with historical survival, RFA appears to confer a survival benefit over systemic chemotherapy alone, particularly when it is offered as part of first-line therapy.


Subject(s)
Catheter Ablation , Colorectal Neoplasms/pathology , Liver Neoplasms/secondary , Liver Neoplasms/therapy , Adult , Aged , Aged, 80 and over , Humans , Middle Aged , Prognosis , Survival Analysis , Time Factors
3.
Surg Clin North Am ; 84(4): 1085-111, vi-i, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15261754

ABSTRACT

Intraoperative ultrasound (IOUS) can provide various diagnostic information that is otherwise not available, and can guide or assist various surgical procedures in real time. With refinement of equipment, IOUS is currently used in a wide variety of surgical operations,such as hepatobiliary, pancreatic, endocrine, cardiovascular,and neurologic surgery. Our overview of IOUS, including instrumentation,techniques, indications, advantages, disadvantages,and future perspective, is described in this article. Being safe, quick, accurate, and versatile intraoperatively, IOUS is a valuable technique that surgeons are recommended to master to improve intraoperative decision making and surgical procedures.


Subject(s)
Digestive System Diseases/diagnostic imaging , Digestive System Diseases/surgery , Surgical Procedures, Operative/methods , Ultrasonography, Interventional , Biliary Tract Diseases/diagnostic imaging , Biliary Tract Diseases/surgery , Cardiovascular Diseases/diagnostic imaging , Cardiovascular Diseases/surgery , Cholangiography , Endocrine System Diseases/diagnostic imaging , Endocrine System Diseases/surgery , Foreign Bodies/diagnostic imaging , Foreign Bodies/surgery , Gallbladder Diseases/diagnostic imaging , Gallbladder Diseases/surgery , Humans , Intraoperative Period , Liver Diseases/diagnostic imaging , Liver Diseases/surgery , Liver Neoplasms/diagnostic imaging , Liver Neoplasms/surgery , Pancreatic Neoplasms/diagnostic imaging , Pancreatic Neoplasms/surgery , Transducers
4.
J Clin Ultrasound ; 32(1): 1-7, 2004 Jan.
Article in English | MEDLINE | ID: mdl-14705170

ABSTRACT

PURPOSE: The aim of this in vitro study was to assess the feasibility of using high-frequency sonography to identify colorectal lymph nodes and to diagnose colorectal lymph node metastasis. METHODS: In part 1 of this study, resected colorectal tissues from 13 patients with colorectal cancer were scanned in a water bath using B-mode sonography performed at high frequency (10 MHz) to identify lymph nodes. The colorectal tissues were then carefully dissected to remove all lymph nodes. Detectability was calculated as the ratio of the number of sonographically detected nodes to the total number of histopathologically confirmed nodes. Student's t test was performed to compare sizes between these groups; a p value of less than 0.05 was considered significant. In part 2, 4 features of lymph nodes identified on B-mode sonography--size, shape, border, and echogenicity--and their combinations were evaluated for their ability to diagnose lymph node metastasis. Discriminant and receiver operating characteristic curve analyses were performed. RESULTS: In part 1, B-mode sonography performed in vitro detected 79 (48%) of the 165 histopathologically identified lymph nodes and 34 (87%) of the 39 histopathologically identified metastatic nodes. The mean size, or mean longest axis (+/- standard deviation), of the sonographically detected nodes (6.4 +/- 2.9 mm) was significantly larger than that of undetected nodes (3.6 +/- 1.7 mm; p < 0.01). In part 2, the most effective feature distinguishing metastatic from nonmetastatic lymph nodes was echogenicity, followed by size, shape, and border. However, a combination of at least 2 features (eg, echogenicity and size) provided better distinction of nodes than did any 1 feature. In the receiver operating characteristic curve of the 4-feature combination, an increase in sensitivity is accompanied by a decrease in specificity: at a sensitivity of 100%, specificities decreased to 60% or less. However, even with the optimal combination of features, the sensitivity and specificity did not both reach 85% at any operating point. CONCLUSIONS: The results of this node-by-node in vitro study show the current limitations and potential of sonography for assessing colorectal lymph nodes. High-frequency sonography may be insufficient for identifying lymph node metastasis in colorectal cancer.


Subject(s)
Adenocarcinoma/diagnostic imaging , Colorectal Neoplasms/diagnostic imaging , Lymphatic Metastasis/diagnostic imaging , Adenocarcinoma/secondary , Adenocarcinoma/surgery , Aged , Aged, 80 and over , Colorectal Neoplasms/pathology , Colorectal Neoplasms/surgery , Endosonography , Feasibility Studies , Female , Humans , Male , Middle Aged , Prospective Studies , ROC Curve , Sensitivity and Specificity
5.
J Ultrasound Med ; 22(5): 507-13, 2003 May.
Article in English | MEDLINE | ID: mdl-12751862

ABSTRACT

OBJECTIVE: To evaluate the feasibility of sonographically guided radio frequency thermal ablation as a minimally invasive method for treatment of unresectable recurrent or metastatic tumors in the retroperitoneum and the pelvis, which often pose difficult surgical problems. METHODS: Radio frequency thermal ablation was performed on 7 patients with unresectable recurrent retroperitoneal or pelvic tumors from colorectal (n = 4), renal (n = 2), and prostate (n = 1) cancers. Under sonographic guidance, a total of 11 radio frequency thermal ablation operations were performed by a percutaneous or transanal approach. RESULTS: Three patients were asymptomatic, whereas 4 patients were symptomatic. The sizes of the tumors ranged from 29 to 100 mm (mean, 50.5 mm). Radio frequency thermal ablation was technically completed in all operations without intraoperative complications. The ablation time ranged from 25 to 238 minutes depending on the tumor size. There was no mortality. There were postoperative complications in 3 operations (27.3%): an enterovesical fistula, a skin burn, and fecal incontinence. The hospital stay was generally 0 to 1 day. Tumor marker levels decreased after radio frequency thermal ablation in all operations. Symptoms of 4 patients were controlled by radio frequency thermal ablation. One patient with recurrent renal cancer and uncontrollable hypercalcemia became asymptomatic immediately after radio frequency thermal ablation. Local recurrence at the radio frequency thermal ablation site occurred in 2 patients (28.6%), but these local recurrent tumors were treated effectively by additional sonographically guided radio frequency thermal ablation. CONCLUSIONS: Minimally invasive sonographically guided radio frequency thermal ablation is technically feasible for local treatment of unresectable recurrent retroperitoneal and pelvic tumors from different origins. Care should be taken to avoid thermal injury to surrounding organs. Further study is needed to evaluate its safety and efficacy.


Subject(s)
Catheter Ablation/methods , Colorectal Neoplasms/pathology , Neoplasm Recurrence, Local/surgery , Pelvic Neoplasms/surgery , Prostatic Neoplasms/pathology , Retroperitoneal Neoplasms/surgery , Aged , Aged, 80 and over , Feasibility Studies , Female , Humans , Male , Middle Aged , Palliative Care , Pelvic Neoplasms/diagnostic imaging , Pelvic Neoplasms/secondary , Retroperitoneal Neoplasms/diagnostic imaging , Retroperitoneal Neoplasms/secondary , Ultrasonography, Interventional
6.
Surg Laparosc Endosc Percutan Tech ; 12(3): 160-4, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12080255

ABSTRACT

Ultrasound-guided radiofrequency thermal ablation has been performed for liver tumors by percutaneous, laparoscopic, or open surgical approaches. Each approach has specific advantages and disadvantages. Herein we describe a new technique for hand-assisted laparoscopic ultrasound-guided radiofrequency thermal ablation of liver tumors. A hand-access device is placed at the right or central portion of the abdomen, in addition to standard trocars. A conventional intraoperative ultrasound probe, with an ultrasound guidance system attached, is inserted into the peritoneal cavity together with the surgeon's hand. After pneumoperitoneum is established, an electrode-cannula for thermal ablation is introduced subcostally or intercostally, and advanced into a liver tumor under direct guidance by intraoperative ultrasound. We have used this technique in eight patients with unresectable liver tumors. Precise guidance of the cannula into tumors was possible. All tumors were well ablated. The postoperative recovery of patients was of shorter duration compared with that of an open surgical approach. A hand-assisted laparoscopic ultrasound-guided method has advantages of both laparoscopic and open surgical approaches for radiofrequency thermal ablation treatment of liver tumors. Accurate cannula insertion is possible with the ultrasound guidance system. The hand-assisted laparoscopic approach can become an additional useful technique, particularly as a valuable alternative to an open surgical method, for performing radiofrequency thermal ablation.


Subject(s)
Carcinoma, Hepatocellular/surgery , Catheter Ablation/instrumentation , Catheter Ablation/methods , Laparoscopes , Laparoscopy/methods , Liver Neoplasms/surgery , Ultrasonography, Interventional/methods , Carcinoma, Hepatocellular/diagnostic imaging , Colorectal Neoplasms/diagnostic imaging , Colorectal Neoplasms/pathology , Equipment Design , Humans , Intraoperative Complications/diagnosis , Intraoperative Complications/diagnostic imaging , Intraoperative Complications/surgery , Liver Neoplasms/diagnostic imaging , Liver Neoplasms/secondary , Man-Machine Systems , Neoplasms, Unknown Primary/diagnosis , Neoplasms, Unknown Primary/diagnostic imaging , Neoplasms, Unknown Primary/surgery , Postoperative Complications/diagnostic imaging
SELECTION OF CITATIONS
SEARCH DETAIL
...